HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis.

Abstract
In the treatment of group A beta-hemolytic streptococcal pharyngitis, penicillin is the drug of choice and erythromycin is the alternative. In a double-blind, randomized study, dirithromycin, a new macrolide, was compared with penicillin for the treatment of streptococcal pharyngitis. Of 121 patients who were treated with dirithromycin, 96.7% manifested a favorable clinical response, and of 136 patients treated with penicillin, 94.2% manifested a favorable clinical response. Streptococci were eradicated from the pharynges of 85.3% of 116 dirithromycin-treated patients and 82.5% of 126 penicillin-treated patients who returned for follow-up. There were no statistically significant differences in efficacy between the two groups. The incidence of abdominal symptoms was higher in dirithromycin-treated patients. Being as efficacious as penicillin and having the advantages over erythromycin of once-daily dosing and the lack of drug interactions, dirithromycin is an alternative to penicillin in the treatment of streptococcal pharyngitis for patients 12 years of age and older.
AuthorsV S Watkins, M Smietana, P M Conforti, G D Sides, W Huck
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 41 Issue 1 Pg. 72-5 (Jan 1997) ISSN: 0066-4804 [Print] United States
PMID8980757 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Macrolides
  • Penicillins
  • dirithromycin
  • Erythromycin
Topics
  • Adolescent
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Double-Blind Method
  • Drug Therapy, Combination (therapeutic use)
  • Erythromycin (analogs & derivatives, therapeutic use)
  • Female
  • Humans
  • Macrolides
  • Male
  • Penicillins (therapeutic use)
  • Pharyngitis (drug therapy, microbiology)
  • Streptococcal Infections (drug therapy, microbiology)
  • Streptococcus pyogenes (drug effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: